HALOZYME THERAPEUTICS, INC. Quarterly Interest Expense in USD from Q1 2012 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Halozyme Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2012 to Q1 2024.
  • Halozyme Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $4.51M, a 0.79% decline year-over-year.
  • Halozyme Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $18.7M, a 5.09% decline year-over-year.
  • Halozyme Therapeutics, Inc. annual Interest Expense for 2023 was $18.8M, a 10.7% increase from 2022.
  • Halozyme Therapeutics, Inc. annual Interest Expense for 2022 was $16.9M, a 125% increase from 2021.
  • Halozyme Therapeutics, Inc. annual Interest Expense for 2021 was $7.53M, a 63.1% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $18.7M $4.51M -$36K -0.79% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $18.8M $5.22M +$650K +14.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 $18.1M $4.51M -$3.01M -40% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $21.1M $4.49M +$1.39M +44.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $19.7M $4.54M +$2.78M +158% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $16.9M $4.57M +$2.52M +122% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 $14.4M $7.51M +$5.76M +328% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $8.67M $3.1M +$1.35M +77.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $7.32M $1.76M -$206K -10.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $7.53M $2.06M -$2.98M -59.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $10.5M $1.75M -$3.24M -64.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $13.7M $1.75M -$3.25M -65% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $17M $1.97M -$3.38M -63.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $20.4M $5.04M +$1.31M +35% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-21
Q3 2020 $19.1M $4.99M +$2.91M +140% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $16.2M $5M +$2.39M +91.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $13.8M $5.35M +$2.14M +66.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $11.6M $3.73M -$24K -0.64% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-22
Q3 2019 $11.7M $2.08M -$2.21M -51.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-02
Q2 2019 $13.9M $2.61M -$2.16M -45.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $16M $3.21M -$2.03M -38.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $18M $3.76M -$1.7M -31.2% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-23
Q3 2018 $19.7M $4.29M -$1.25M -22.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $21M $4.77M -$770K -13.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $21.8M $5.23M -$218K -4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $22M $5.46M -$141K -2.52% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-24
Q3 2017 $22.1M $5.54M +$285K +5.43% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $21.8M $5.54M +$291K +5.54% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $21.5M $5.45M +$1.57M +40.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $20M $5.6M +$4.3M +330% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-21
Q3 2016 $15.7M $5.25M +$3.95M +304% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $11.7M $5.25M +$3.95M +304% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $7.78M $3.88M +$2.58M +198% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $5.2M $1.3M -$76K -5.52% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-20
Q3 2015 $5.28M $1.3M -$75K -5.45% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $5.35M $1.3M -$152K -10.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $5.5M $1.3M -$77K -5.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $5.58M $1.38M +$651K +89.5% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-28
Q3 2014 $4.93M $1.38M +$526K +61.9% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $4.4M $1.45M +$602K +70.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $3.8M $1.38M +$528K +62.3% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $3.27M $727K +$727K Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $2.55M $850K +$850K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $1.7M $849K +$849K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 $848K $848K +$848K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $0 $0 Oct 1, 2012 Dec 31, 2012 10-K 2015-03-02
Q3 2012 $0 Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 $0 Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-07
Q1 2012 $0 Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.